Variant report
Variant | esv2763787 |
---|---|
Chromosome Location | chr4:59974071-59990876 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs534462615 | chr4:59975804-59975805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs6551577 | chr4:59975809-59975810 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs574379624 | chr4:59975813-59975814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs541792140 | chr4:59975919-59975920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs556850062 | chr4:59975923-59975924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs371361309 | chr4:59975935-59975936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs575165521 | chr4:59975949-59975950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs545596649 | chr4:59975950-59975951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs374401785 | chr4:59975956-59975957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs563897220 | chr4:59975981-59975982 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181129783 | chr4:59976036-59976037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs185974468 | chr4:59976048-59976049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs367977757 | chr4:59976091-59976092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs113074328 | chr4:59976123-59976124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs112042771 | chr4:59976128-59976129 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs529286789 | chr4:59976133-59976134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs372131252 | chr4:59976138-59976139 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs550924102 | chr4:59976147-59976148 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs190930031 | chr4:59976155-59976156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs533628677 | chr4:59976163-59976164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs571975835 | chr4:59976170-59976171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs183956607 | chr4:59976207-59976208 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs567119363 | chr4:59976235-59976236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs149666209 | chr4:59976260-59976261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs187844267 | chr4:59976292-59976293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs568111040 | chr4:59976319-59976320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs535123911 | chr4:59976326-59976327 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs190735033 | chr4:59976333-59976334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs183020790 | chr4:59976343-59976344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs13110374 | chr4:59976351-59976352 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs368483109 | chr4:59976353-59976354 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs557626659 | chr4:59976380-59976381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs572981447 | chr4:59976385-59976386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs540389749 | chr4:59976402-59976403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs368322335 | chr4:59976477-59976478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs187313809 | chr4:59976478-59976479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544626495 | chr4:59976499-59976500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs370048409 | chr4:59976517-59976518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs192727267 | chr4:59976528-59976529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs564432320 | chr4:59976529-59976530 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs540070986 | chr4:59976549-59976550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs552133747 | chr4:59976576-59976577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs145111090 | chr4:59976577-59976578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs527893337 | chr4:59976585-59976586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs540795388 | chr4:59976604-59976605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs184688526 | chr4:59976623-59976624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs568062845 | chr4:59976642-59976643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs187666755 | chr4:59976643-59976644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs192585961 | chr4:59976645-59976646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs6843543 | chr4:59976665-59976666 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Lung cancer | 18438408 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Prostate cancer | 16573809 | CNVD |
Osteoporosis | 18992858 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:59975800-59977600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr4:59977600-59977800 | ZNF genes & repeats | iPS DF 6.9 Cell Line | embryonic stem cell |
3 | chr4:59985000-59986200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr4:59985000-59987200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr4:59985400-59987000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr4:59986000-59986400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr4:59986200-59987000 | Enhancers | A549 | lung |
8 | chr4:59986200-59988200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
9 | chr4:59986400-59986800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
10 | chr4:59986400-59987200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr4:59986800-59987000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
12 | chr4:59986800-59987000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
13 | chr4:59987000-59988200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
14 | chr4:59987000-59991000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
15 | chr4:59987200-59988200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
16 | chr4:59987200-59990800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
17 | chr4:59988200-59988400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
18 | chr4:59988200-59988400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
19 | chr4:59988200-59988600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
20 | chr4:59990800-59991200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |